Pratidin
2026 · Medical Science Optional Paper I · 10 marksMainsQuestion 5d

Describe the laboratory diagnosis and immunophenotypic classification of acute lymphoblastic leukaemia.

10 marks · directive: Describe

Answer

The core of a good answer

Acute lymphoblastic leukaemia is diagnosed by blood counts and smear showing circulating lymphoblasts, confirmed by bone marrow with typically more than 20 percent lymphoblasts, flow cytometry immunophenotyping (TdT expressed, myeloperoxidase not expressed), cytogenetics and molecular tests for prognostic lesions such as ETV6-RUNX1, BCR-ABL1 and KMT2A rearrangement, and lumbar puncture; immunophenotypically it is B-lineage ALL (CD19, CD22, CD79a; with stages such as common ALL, pre-B and mature B) in about 85 percent and T-lineage ALL (CD2, CD3, CD5, CD7) in about 15 percent.

An outline written by upsc.help, not an official UPSC answer; every fact checked by a separate review. How we work

What the question asks

Two parts: a stepwise laboratory work-up from blood count to molecular tests, and a classification by lineage and maturation stage with marker profiles. A table of markers scores well.

Answer outline

Introduction

Acute lymphoblastic leukaemia (ALL) is a malignant proliferation of immature lymphoid cells (lymphoblasts); it is the commonest childhood cancer, peaking between 3 and 7 years.

Laboratory diagnosis

Immunophenotypic classification

Older morphological classification (FAB)

Conclusion

Morphology suggests ALL, but immunophenotyping and genetics confirm lineage, stage and risk, which together decide treatment.

Examples and data to cite

Facts

Facts to remember

Sources used for the explanation

Write a timed answer in the app